Literature DB >> 20085729

More is not always better: alpha2A-adrenoceptor expression in type 2 diabetes.

Jürgen Wess.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20085729     DOI： 10.1016/j.cmet.2009.12.002

Source DB:  PubMed          Journal:  Cell Metab        ISSN： 1550-4131            Impact factor:   27.287


× No keyword cloud information.
  3 in total

1.  Mechanisms of antihyperglycaemic action of efaroxan in mice: time for reappraisal of α2A-adrenergic antagonism in the treatment of type 2 diabetes?

Authors:  Z Lehner; K Stadlbauer; I Adorjan; I Rustenbeck; M Belz; A Fenzl; V A M de Cillia; D Gruber; L Bauer; K Frobel; B Brunmair; A Luger; C Fürnsinn
Journal:  Diabetologia       Date:  2012-08-18       Impact factor: 10.122

2.  Function and expression of sulfonylurea, adrenergic, and glucagon-like peptide 1 receptors in isolated porcine islets.

Authors:  Amy C Kelly; Leah V Steyn; Jenna P Kitzmann; Miranda J Anderson; Kate R Mueller; Nathaniel J Hart; Ronald M Lynch; Klearchos K Papas; Sean W Limesand
Journal:  Xenotransplantation       Date:  2014-05-07       Impact factor: 3.907

3.  Evidence that the multiflorine-derived substituted quinazolidine 55P0251 augments insulin secretion and lowers blood glucose via antagonism at α2 -adrenoceptors in mice.

Authors:  Zsuzsanna Lehner; Karin Stadlbauer; Barbara Brunmair; Immanuel Adorjan; Miroslav Genov; Alexandra Kautzky-Willer; Thomas Scherer; Mika Scheinin; Leonhardt Bauer; Clemens Fürnsinn
Journal:  Diabetes Obes Metab       Date:  2019-11-07       Impact factor: 6.577
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.